ECSP045171A - Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia - Google Patents

Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia

Info

Publication number
ECSP045171A
ECSP045171A EC2004005171A ECSP045171A ECSP045171A EC SP045171 A ECSP045171 A EC SP045171A EC 2004005171 A EC2004005171 A EC 2004005171A EC SP045171 A ECSP045171 A EC SP045171A EC SP045171 A ECSP045171 A EC SP045171A
Authority
EC
Ecuador
Prior art keywords
concept
pharmaceutical composition
dosage regime
emergency anti
emergency
Prior art date
Application number
EC2004005171A
Other languages
English (en)
Inventor
Look Paul F A Van
Illesne Balgoh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet Gyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet Gyar Rt filed Critical Richter Gedeon Vegyeszet Gyar Rt
Publication of ECSP045171A publication Critical patent/ECSP045171A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
EC2004005171A 2001-11-27 2004-06-25 Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia ECSP045171A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel

Publications (1)

Publication Number Publication Date
ECSP045171A true ECSP045171A (es) 2004-08-27

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005171A ECSP045171A (es) 2001-11-27 2004-06-25 Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia

Country Status (33)

Country Link
US (1) US20050288264A2 (es)
EP (1) EP1448207B1 (es)
JP (1) JP2005516904A (es)
KR (1) KR100908161B1 (es)
CN (1) CN1551774A (es)
AP (1) AP1849A (es)
AT (1) ATE293978T1 (es)
AU (1) AU2002347401A1 (es)
BR (1) BR0210595A (es)
CA (1) CA2450359C (es)
DE (1) DE60203929T2 (es)
DK (1) DK1448207T3 (es)
EA (1) EA006545B1 (es)
EC (1) ECSP045171A (es)
ES (1) ES2239727T3 (es)
GE (1) GEP20063882B (es)
HR (1) HRP20040584B1 (es)
HU (1) HU227198B1 (es)
IL (1) IL159394A0 (es)
IS (1) IS2691B (es)
MA (1) MA27076A1 (es)
MX (1) MXPA04005104A (es)
NO (1) NO333984B1 (es)
NZ (1) NZ530056A (es)
OA (1) OA12730A (es)
PL (1) PL206010B1 (es)
PT (1) PT1448207E (es)
RS (1) RS50768B (es)
SI (1) SI1448207T1 (es)
TN (1) TNSN04048A1 (es)
UA (1) UA79942C2 (es)
WO (1) WO2003045397A1 (es)
ZA (1) ZA200404114B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867515B2 (en) * 2006-12-20 2011-01-11 TEVA Woman's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
JP2011507853A (ja) * 2007-12-20 2011-03-10 テバ ウィメンズ ヘルス インコーポレイテッド 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
WO2010066883A1 (en) * 2008-12-12 2010-06-17 Laboratoire Hra-Pharma A method for contraception
US9616073B2 (en) 2009-04-14 2017-04-11 Laboratoire Hra-Pharma Method for on-demand contraception
JP5801801B2 (ja) * 2009-06-23 2015-10-28 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 緊急避妊のための医薬組成物及び処置方法
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
SG195121A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
CN107266514A (zh) 2011-06-01 2017-10-20 埃斯特拉私人有限责任公司 用于产生雌四醇中间体的方法
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
LT2741824T (lt) * 2011-08-11 2017-06-26 Estetra S.P.R.L. Estetrolio panaudojimas kaip skubaus kontraceptiko
AU2013349776A1 (en) 2012-11-22 2015-05-28 Bayer Pharma Aktiengesellschaft Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
CN105451737B (zh) 2013-05-23 2018-04-10 拜耳医药股份有限公司 药物组合物及其用途以及所述药物组合物用于按需避孕的施用方法
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
CN107810001A (zh) 2015-06-18 2018-03-16 密特拉制药公司 含雌四醇的口腔分散片剂
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
EP3310333B1 (en) 2015-06-18 2020-04-29 Estetra SPRL Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception

Also Published As

Publication number Publication date
HRP20040584B1 (en) 2012-11-30
DE60203929D1 (de) 2005-06-02
NZ530056A (en) 2005-02-25
OA12730A (fr) 2006-06-28
IS7065A (is) 2003-12-05
NO20041607L (no) 2004-04-20
JP2005516904A (ja) 2005-06-09
AP1849A (en) 2008-05-23
RS4204A (en) 2007-02-05
CA2450359C (en) 2011-05-10
CA2450359A1 (en) 2003-06-05
EP1448207B1 (en) 2005-04-27
RS50768B (sr) 2010-08-31
BR0210595A (pt) 2004-06-08
IS2691B (is) 2010-10-15
ZA200404114B (en) 2005-10-26
WO2003045397A1 (en) 2003-06-05
MA27076A1 (fr) 2004-12-20
CN1551774A (zh) 2004-12-01
EP1448207A1 (en) 2004-08-25
KR100908161B1 (ko) 2009-07-16
US20050032755A1 (en) 2005-02-10
SI1448207T1 (en) 2005-10-31
AP2004003046A0 (en) 2004-06-30
HUP0105173D0 (en) 2002-02-28
IL159394A0 (en) 2004-06-01
MXPA04005104A (es) 2004-08-19
HRP20040584A2 (en) 2005-02-28
UA79942C2 (en) 2007-08-10
EA200400731A1 (ru) 2004-12-30
PL369520A1 (en) 2005-04-18
GEP20063882B (en) 2006-07-25
HUP0105173A3 (en) 2004-03-29
HUP0105173A2 (hu) 2003-08-28
DK1448207T3 (da) 2005-06-27
EA006545B1 (ru) 2006-02-24
PL206010B1 (pl) 2010-06-30
AU2002347401A1 (en) 2003-06-10
US20050288264A2 (en) 2005-12-29
DE60203929T2 (de) 2006-01-19
NO333984B1 (no) 2013-11-04
PT1448207E (pt) 2005-08-31
HU227198B1 (en) 2010-10-28
ATE293978T1 (de) 2005-05-15
ES2239727T3 (es) 2005-10-01
TNSN04048A1 (en) 2006-06-01
KR20040066088A (ko) 2004-07-23

Similar Documents

Publication Publication Date Title
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
FI20011478A (fi) Farmaseuttinen koostumus
NO20033384L (no) Farmasoytisk formulering
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
AR028317A1 (es) Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
NO20033785L (no) Farmasöytisk formulering
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
DE60219051D1 (de) Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
NO20035627D0 (no) Farmasöytisk formulering
AR028023A1 (es) Una composicion farmaceutica para el tratamiento de la hiperlipidemia y el uso de dicha composicion para la preparacion de medicamentos
FI20022128A (fi) Farmaseuttinen koostumus
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
GB0322848D0 (en) Tetracycline controlled release pharmaceutical dosage form
MXPA03009100A (es) Composicion farmaceutica y procedimiento de obtencion respectivo.
DE10107261B4 (de) Pharmazeutische Zusammensetzung
DE60218683D1 (de) Pharmazeutische zusammensetzung für die nasale verabreichung von östradiol und norethisteron
NO20041236L (no) Farmasoytisk formulering
FI5468U1 (fi) Farmaseuttinen koostumus